Can visceral hemangiomas be part of Klippel-Trenaunay syndrome (KTS) and how are they managed?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Visceral hemangiomas can be a part of Klippel-Trenaunay syndrome (KTS), and their management depends on their location, size, and associated symptoms. The diagnosis of KTS is based on the presence of capillary malformations, venous malformations, and limb overgrowth, but visceral hemangiomas can occur less frequently as part of the syndrome 1.

Key Considerations for Diagnosis

  • The classification of vascular anomalies, as adopted by the International Society for the Study of Vascular Anomalies, is crucial for accurate diagnosis and management 1.
  • Visceral hemangiomas in KTS can affect various organs, including the gastrointestinal tract, liver, spleen, or genitourinary system, with varying clinical implications.

Management Approach

  • Asymptomatic visceral hemangiomas are typically monitored with regular imaging (ultrasound, MRI, or CT scans) every 6-12 months.
  • For symptomatic lesions, treatment options include pharmacological therapy with propranolol (starting at 0.5-1 mg/kg/day divided into three doses, gradually increasing to 2-3 mg/kg/day) or sirolimus (0.8 mg/m² twice daily, adjusted to maintain trough levels of 5-15 ng/mL) 1.
  • Interventional procedures such as embolization may be necessary for bleeding hemangiomas, while surgical resection is reserved for cases with severe symptoms, complications, or failure of other treatments.

Multidisciplinary Care

  • Multidisciplinary care involving vascular specialists, interventional radiologists, and surgeons is essential for optimal management of visceral hemangiomas in KTS.
  • The approach to visceral hemangiomas in KTS requires individualization based on the specific organ involvement and associated symptoms 1.

From the Research

Diagnosis of Klippel-Trenaunay Syndrome

The diagnosis of Klippel-Trenaunay syndrome (KTS) is based on the clinical triad of:

  • Capillary malformations (port wine stain)
  • Soft tissue and bone hypertrophy or hypotrophy of usually one lower limb
  • Atypical, mostly lateral varicosity 2, 3, 4 A thorough history and clinical examination is enough for the diagnosis of KTS in most cases, but noninvasive imaging techniques may be used to evaluate the disease in patients with certain complications 3.

Visceral Hemangiomas in Klippel-Trenaunay Syndrome

Visceral hemangiomas can be part of KTS, as the syndrome may affect internal organs 5. KTS is a mixed vascular malformation, with predominant capillary, venous, and lymphatic components, without significant arteriovenous shunting 2. The management of visceral hemangiomas in KTS is not specifically discussed in the available studies, but a multidisciplinary approach to management of KTS is warranted 2, 3.

Management of Klippel-Trenaunay Syndrome

The management of KTS is largely conservative and includes:

  • Compression therapy to reduce edema due to chronic venous insufficiency
  • Laser treatment for port wine stains
  • Sclerotherapy, endovenous thermal ablation, or surgical stripping and phlebectomy for superficial veins and malformations 2, 6 A multidisciplinary approach to management of KTS is essential due to the diversity of presentation 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Klippel-Trénaunay Syndrome: Need for Careful Clinical Classification.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine, 2016

Research

Klippel-Trenaunay Syndrome: A Case Report.

Journal of Nepal Health Research Council, 2016

Research

Klippel-trénaunay syndrome - a very rare and interesting syndrome.

Clinical medicine insights. Circulatory, respiratory and pulmonary medicine, 2015

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.